Additionally, paste this code immediately after the opening tag:

Study 200195 App

Study 200195 App’s purpose is to support GSK Study 200195 (Adenosine Deaminase Severe Combined Immunodeficienc...

Free

Store review

Study 200195 App’s purpose is to support GSK Study 200195 (Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) Registry for Patients Treated with Strimvelis™ (or GSK269273) Gene Therapy: Long-Term Prospective, Non-Interventional Follow-up of Safety and Effectiveness). Registry participant’s will be able to use the app to enter the required information for the study.

Last update

Nov. 26, 2019

Read more